The global personalized medicine market to reach $733.27 billion by 2030 at 11.8% cagr, driven by growing obese population.
Read More
Personalized genomics market to reach $19.61 billion by 2030 at 15.7% cagr, driven by rising prevalence of chronic diseases.
Read More
Personalized gene therapy treatment market to reach $21.23 billion by 2030 at 20.4% cagr, driven by growing prevalence of genetic disorders.
Read More
Personalized dietary supplements market to reach $15.72 billion by 2030 at 10.9% cagr, driven by rising prevalence of lifestyle-related diseases.
Read More
Personalized cancer vaccines market to reach $350.3 billion by 2030 at 6.4% cagr, driven by increasing prevalence of cancer.
Read More
Peripheral vasodilator drugs market to reach $8.56 billion by 2030 at 5.2% cagr, driven by increasing prevalence of cardiovascular diseases.
Read More
Pericarditis drugs market to reach $5.1 billion by 2030 at 9.0% cagr, driven by increasing prevalence of autoimmune diseases.
Read More
Pericarditis market to reach $3.64 billion by 2030 at 7.9% cagr, driven by increasing prevalence of cardiovascular diseases.
Read More
Perfusion bioreactor with artificial intelligence control market to reach $4.85 billion by 2030 at 20.8% cagr, driven by increasing prevalence of personalized medicine.
Read More
Performance enhancing drugs market to reach $14.91 billion by 2030 at 5.4% cagr, driven by rising interest in fitness activities.
Read More